RxDoctor Payments Data

Ikemefuna Onyekwelu, MD

Orthopaedic Surgery · Little Rock, ARNPI 1770838443

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (45.6%), food and beverage and royalties or licence payments — rather than concentrated in one kind of arrangement. 14 manufacturers reported payments, led by Degen Medical, Inc. at 41.1% of the total. Reporting peaked in 2019 at $4,415 and has fallen 61.3% since, to $1,707 in 2025.

$10,818in general payments, 2019–2025

Across 75 payments — averaging $144.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Degen Medical, Inc.$4K
  • Medtronic$2K
  • Globus Medical$2K
  • Stryker$2K
  • Amgen$155
  • Johnson & Johnson$75
  • plus $241 from 8 others
$1,500in research payments, 2019–2025

Across 1 payment — averaging $1499.94 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Medtronic$1K

What the payments were for

  • Royalty or licence$1,50014%
  • Consulting fees$9008%
  • Travel & lodging$4,93646%
  • Food & beverage$3,05328%
  • Education$4304%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$10,818 in reported general payments places this provider in the 75th percentile of 168 orthopaedic surgery providers in Arkansas.

See all orthopaedic surgery providers in Arkansas

Medicare billing

Part B allowed, 2024
$409,689
Medicare patients
335
Services billed
1,854

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Tizanidine Hcl171$1,370
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen77$1,167
Pregabalin28$763
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen62$698
Gabapentin121$689
Methocarbamol51$483
Celecoxib20$386
Tramadol Hcl62$256
Meloxicam70$186
Methylprednisolone29$186
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim16$62
Alprazolam30$43

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Little Rock

See the full list for Arkansas

Where these figures come from

Is this you, or does something look wrong? →